News

Ixekizumab improved psoriatic arthritis in patients who had not taken biologics
Key clinical point: Ixekizumab improved signs and symptoms of active psoriatic arthritis in a phase III manufacturer-sponsored trial of patients...
Key clinical point: Ixekizumab improved signs and symptoms of active psoriatic arthritis in a phase III manufacturer-sponsored trial of patients...
Progress in treating ischemic heart disease has resulted in more patients with heart failure, and we must work to develop more effective heart...
Key clinical point: Psoriasis patients have increased coronary artery calcium levels similar to those seen in type 2 diabetes patients, suggesting...